🧬Prospective Exclusive Patent License for Cancer Treatment Innovations
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an NCI Exclusive Patent License to practice the inventions embodied in the patents listed in the Supplementary Information section of this notice to Lysin Therapeutics, Inc. (Lysin), a company located in Silver Spring, MD.
Learn More📜Notice of Intent to Grant Exclusive Patent License by Air Force
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license agreement to The University of Cincinnati, a State of Ohio institute of higher education, having a place of business at 2900 Reading Road, Suite 460, Cincinnati, OH 45206-0829.
Learn More🛠️Notice of Intent to Grant Exclusive Patent License to ColdQuanta
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license to ColdQuanta, Inc., a Delaware corporation dba Infleqtion, having a place of business at 3030 Sterling Cir., Boulder, CO 80301-2338.
Learn More🚀NASA's Intent to Grant Exclusive Patent Licenses Overview
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More